PAPER Nash KR, Moran P, Finneran DJ, Hudson C, Robinson J, Morgan D, Bickford PC
SEARCH RESULTS
331008 RESULTS
PAPER Al-Chalabi A, Visscher PM
Motor neuron disease: Common genetic variants and the heritability of ALS.
Nat Rev Neurol. 2014 Oct;10(10):549-50. Epub 2014 Sep 9 PubMed: 25201239PAPER Atsuta N, Nakamura R, Watanabe H, Sobue G
[Japanese Consortium for Amyotrophic Lateral Sclerosis research (JaCALS)].
Brain Nerve. 2014 Sep;66(9):1090-6. PubMed: 25200580PAPER Suárez-Calvet M, Camacho V, Gómez-Ansón B, Antón S, Vives-Gilabert Y, Dols-Icardo O, Clarimón J, Alcolea D, Blesa R, Fortea J, Lleó A
Early Cerebellar Hypometabolism in Patients With Frontotemporal Dementia Carrying the C9orf72 Expansion.
Alzheimer Dis Assoc Disord. 2014 Sep 8; PubMed: 25203513PAPER Mansoor Y, Jastrzab L, Dutt S, Miller BL, Seeley WW, Kramer JH
Memory Profiles in Pathology or Biomarker Confirmed Alzheimer Disease and Frontotemporal Dementia.
Alzheimer Dis Assoc Disord. 2014 Sep 8; PubMed: 25203512PAPER Chami M, Checler F
Ryanodine receptors: dual contribution to Alzheimer disease?
Channels (Austin). 2014;8(3):168. PubMed: 25203457PAPER Raley KA, Hutchison AM
Statin use and cognitive changes in elderly patients with dementia.
Consult Pharm. 2014 Jul;29(7):487-9. PubMed: 25203109PAPER Lin F, Jia J, Qin W
Enhancement of β-amyloid oligomer accumulation after intracerebroventricular injection of streptozotocin, which involves central insulin signaling in a transgenic mouse model.
Neuroreport. 2014 Nov 12;25(16):1289-95. PubMed: 25202927PAPER El Melik R, Dubil A, Pound MW
Duration of therapy with acetylcholinesterase inhibitors in patients with mild-to-moderate Alzheimer's disease as reported in the literature.
Consult Pharm. 2014 Jun;29(6):400-7. PubMed: 25202893PAPER Bougea A, Gerakoulis S, Anagnostou E, Paraskevas G, Kapaki E, Kararizou E
Donepezil-induced myoclonus in a patient with Alzheimer disease.
Ann Pharmacother. 2014 Dec;48(12):1659-61. Epub 2014 Sep 8 PubMed: 25202036PAPER Zhu XC, Yu Y, Wang HF, Jiang T, Cao L, Wang C, Wang J, Tan CC, Meng XF, Tan L, Yu JT
Physiotherapy intervention in Alzheimer's disease: systematic review and meta-analysis.
J Alzheimers Dis. 2015;44(1):163-74. PubMed: 25201787PAPER Jochemsen HM, van der Flier WM, Ashby EL, Teunissen CE, Jones RE, Wattjes MP, Scheltens P, Geerlings MI, Kehoe PG, Muller M
Angiotensin-converting enzyme in cerebrospinal fluid and risk of brain atrophy.
J Alzheimers Dis. 2015;44(1):153-62. PubMed: 25201786PAPER Gironi M, Borgiani B, Farina E, Mariani E, Cursano C, Alberoni M, Nemni R, Comi G, Buscema M, Furlan R, Grossi E
A global immune deficit in Alzheimer's disease and mild cognitive impairment disclosed by a novel data mining process.
J Alzheimers Dis. 2015;43(4):1199-213. PubMed: 25201785PAPER Hall A, Muñoz-Ruiz M, Mattila J, Koikkalainen J, Tsolaki M, Mecocci P, Kloszewska I, Vellas B, Lovestone S, Visser PJ, Lötjonen J, Soininen H, Alzheimer Disease Neuroimaging Initiative, AddNeuroMed consortium, DESCRIPA and Kuopio L-MCI
Generalizability of the disease state index prediction model for identifying patients progressing from mild cognitive impairment to Alzheimer's disease.
J Alzheimers Dis. 2015;44(1):79-92. PubMed: 25201784PAPER Bozzali M, Dowling C, Serra L, Spanò B, Torso M, Marra C, Castelli D, Dowell NG, Koch G, Caltagirone C, Cercignani M
The impact of cognitive reserve on brain functional connectivity in Alzheimer's disease.
J Alzheimers Dis. 2015;44(1):243-50. PubMed: 25201783Current Filters
No filters selected